Brainomix secures $18M to enhance stroke and lung fibrosis treatment

Brainomix, a company offering AI-powered imaging tools for stroke and lung fibrosis, announced the completion of an $18 million Series C investment round. The round was co-led by existing investors Parkwalk Advisors and the Boehringer Ingelheim Venture Fund. New investor Hostplus via the IP Group Hostplus Innovation Fund and LifeSci Capital participated in the round. […]